Distributed by

Marketed by

Distributed by

Marketed by

BAXTER ONCOLOGY GMBH HALLE/WESTFALEN, GERMANY

Featured products of Baxter Oncology GmbH

Padcev

Padcev powd for IV infusion (lyo) 20 mg

enfortumab vedotin

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX13 - enfortumab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Padcev powd for IV infusion (lyo) 30 mg

enfortumab vedotin

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX13 - enfortumab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Distributed by Zuellig Pharma

Padcev

Padcev powd for IV infusion (lyo) 20 mg

enfortumab vedotin

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX13 - enfortumab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Padcev powd for IV infusion (lyo) 30 mg

enfortumab vedotin

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX13 - enfortumab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Marketed by Astellas Pharma

Padcev

Padcev powd for IV infusion (lyo) 20 mg

enfortumab vedotin

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX13 - enfortumab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Padcev powd for IV infusion (lyo) 30 mg

enfortumab vedotin

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX13 - enfortumab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.